FDA seeks math of similarity

Share this article:

The FDA is looking for mathletes, of a sort. Regulatory Focus reports that the FDA is looking to create a mathematical model that will help regulators assess the sameness of generics and maybe even biosimilars.

RF says the Center for Drug Evaluation and Research will oversee the three-year project which will cost around $1 million.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions